The antagonistic duality of NPM1 mutations in AML

Blood Adv. 2022 Jul 12;6(13):4028-4030. doi: 10.1182/bloodadvances.2022007420.
No abstract available

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation
  • Nuclear Proteins / genetics
  • Nucleophosmin* / genetics

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin